Skip to content

FlowArt Mini Spike - Bag and Vial Access

Original price $2.90 - Original price $2.90
Original price
$2.90
$2.90 - $2.90
Current price $2.90
SKU FLO-ASM5010

FlowArt Mini Spike for bag and vial access with Needle Free Valve.

FlowArt® mini spike with needleless valve is a single-use disposable connector designed to be securely attached to the septum tip of vials. The air can be vented to neutralise the fluid container pressure and is equiped with an integrated silicone seal that protects the patient and nursing staff from exposures as well as minimising the need for needle use and therefore needle stick injuries. It is used to exchange liquids from serum/drug vials and bags without using needles, and to keep the excess drug/serum in reusable vials. The product is latex and PVC free.


Suitable for:

TPN Solutions
Blood
Oncology drugs

Quantity: 100 / Box

Product Code: FLO-ASM5010

Priming Volume: 0.11mL

Length: 5.5cm

** Photoprotective version available upon request - Please use the Contact page to discuss further. 

Features:

  • Fully Transparent Valve
  • Gapless split septum seal
  • Flat closed seal that provides a swabable microbial barrier
  • Suitable for 7 days / 600 activations
  • Enhanced visualisation compared to opaque products
  • Compatible with Luer Slip and Luer Lock syringes
  • ISO 80369 standard compliant - Small-bore connectors for liquids and gases in healthcare applications
  • ISO 80369-7 standard compliant IV sets using luer lock connections.

Suitable for:

  • Lipids
  • Oncology
  • MRI procedures

Research:

The prevalence of reported Needle Stick Injuries (NSIs) in Australia per year was estimated to be 18,000 in Australian hospitals alone before the introduction of Safety Engineered Devices (SEDs) [1-2]. Considering this number is only the reported incidences and underreporting in Australian hospitals is estimated to be 40%, [3] this is a significant hindrance in maintaining a safe work environment. There are a number of diseases that can be transmitted through NSI, including the human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV).  The use of SEDs has been shown to reduce NSIs by up to 31% during a 9-month implementation period. [4]

  1. Cathryn Murphy – (2008), Improved surveillance and mandated use of sharps with engineered sharp injury protections: a national call to action
  2. The Australian Council on Healthcare Standards - (2012) Infection Control version 3.1. Retrospective data in full. Australasian Clinical Indicator Report: 2004—2011. In (13th ed.). Sydney NSW; ACHS.
  3. Australian Safety and Compensation Council – (2008) Occupational Exposures in Australian Nurses. Canberra: Australian Government.
  4. Goris, Ashleigh J., Gemeinhart, Nancy, and Babcock, Hilary M - (2015) “Reducing Needlestick Injuries from Active Safety Devices: A Passive Safety Engineered Device Conversion.” AJIC: American Journal of Infection Control 43.6

Additional Resources